Safety and efficacy of Ofatumumab in chronic lymphocytic leukemia: a systematic review and meta-analysis | |
Wu, Yougen; Wang, Yang; Gu, Yuting; Xia, Ju; Kong, Xiaoyang; Qian, Qingqing; Hong, Yang | |
刊名 | HEMATOLOGY
![]() |
2017 | |
卷号 | 22期号:10 |
关键词 | Anti-CD20 antibody hematological oncology adverse effects progression-free survival overall survival |
ISSN号 | 1024-5332 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3610671 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Wu, Yougen,Wang, Yang,Gu, Yuting,et al. Safety and efficacy of Ofatumumab in chronic lymphocytic leukemia: a systematic review and meta-analysis[J]. HEMATOLOGY,2017,22(10). |
APA | Wu, Yougen.,Wang, Yang.,Gu, Yuting.,Xia, Ju.,Kong, Xiaoyang.,...&Hong, Yang.(2017).Safety and efficacy of Ofatumumab in chronic lymphocytic leukemia: a systematic review and meta-analysis.HEMATOLOGY,22(10). |
MLA | Wu, Yougen,et al."Safety and efficacy of Ofatumumab in chronic lymphocytic leukemia: a systematic review and meta-analysis".HEMATOLOGY 22.10(2017). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论